Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[Pharmacologic treatment of dystonia].

Created on 28 Aug 2026

Authors

Alonso Zea Vera, Graciela Del Pilar Guerrero Ruiz

Published in

Medicina. Volume 86 Suppl 3. Pages 37-42.

Abstract

Dystonia is a significant cause of morbidity and disability in children. Treatment aims to improve function, reduce pain and disability, and enhance the child's quality of life. This review describes the most used pharmacological options for treating persistent dystonia. The main medications used to treat dystonia include anticholinergics, baclofen, and benzodiazepines. Botulinum toxin is also effective, particularly in focal dystonias. Other drugs such as levodopa, gabapentin, clonidine, and vesicular monoamine transporter inhibitors are also frequently used. The most common adverse effects are discussed. Medication selection should consider etiology, subtype of dystonia, potential adverse effects, and associated comorbidities.

PMID:
42659548
Bibliographic data and abstract were imported from PubMed on 28 Aug 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 27
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement